Rusnano’s Grand Ambitions In Biotech
This article was originally published in Start Up
Executive Summary
Now on the ground in Silicon Valley, Russian sovereign fund Rusnano is investing broadly in nanotechnology around the globe, and a lot of those rubles are flowing to US biotech firms, with one major stipulation: help bring innovation and jobs back to Mother Russia.